Back to Trades
ROBINS CHAD M
CEO and ChairmanDirectorCIK 0001780649
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 19
- Companies
- 1
- Active
- 2025–2026
ROBINS CHAD M, CEO and Chairman, Director, has filed 8 SEC reports (2025–2026), all concentrated in Adaptive Biotechnologies Corp (ADPT), totaling $47.7M in disclosed volume. Weighing $0 bought versus $39.8M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Aug 19 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $14.9M |
| Apr 8 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $1.8M |
| Mar 13 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $6.2M |
| Mar 3 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $8.3M |
| Feb 4 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $2.3M |
| Jan 7 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $1.9M |
| Dec 1 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $3.1M |
| Nov 12 | ADPT Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman, Director | Sell | $1.3M |
8 filings